Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xenon
Biotech
Biotech’s top 5 stock picks for 2026: analyst
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch.
Gabrielle Masson
Dec 23, 2025 10:05am
Xenon's MDD med fails ph. 2, elevating seizure potential
Nov 27, 2023 10:45am
Double whammy for Neurocrine as Takeda, Xenon pacts fail
Nov 10, 2023 7:22am
Biohaven veers toward Kv7 platform following Pfizer sale
Oct 4, 2022 11:48am
Xenon frees itself of some XEN1101 milestone obligations
Sep 11, 2018 9:55am
Xenon adds discontinued GSK drug to epilepsy pipeline
Sep 6, 2018 10:20am
